‘Dual action’ weight-loss pill helps people drop 13% of body weight in three months in early trials
An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo Nordisk — the Danish drugmaker behind Ozempic and Wegovy — at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid this … Read more